首页> 美国卫生研究院文献>Indian Journal of Virology >Self Replicating Gene Vaccine Carrying P1-2A Gene of FMDV Serotype O and its Effects on the Immune Responses of Cattle
【2h】

Self Replicating Gene Vaccine Carrying P1-2A Gene of FMDV Serotype O and its Effects on the Immune Responses of Cattle

机译:携带O型FMDV的P1-2A基因的自复制基因疫苗及其对牛免疫反应的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

DNA vaccines are considered as alternatives to live attenuated ones for those diseases like foot-and-mouth disease (FMD) where the production and application of live vaccines have been found unsuccessful. However, stability of DNA and the quantity of antigen expressed are the major limitation with naked DNA vaccines. To address these issues self replicating gene vaccine construct was made for foot-and-mouth disease virus (FMDV) type ‘O’ and studied. The vector for vaccine construct, designated as pSinCMVVac carried CMV promoter and Poly(A) signal sequences at 5′ and 3′ end of Sindbis replicase gene respectively. Gene for structural protein precursor (P1-2A) of FMDV serotype ‘O’ was inserted into pSinCMVVac under subgenomic promoter. 5′UTR (untranslated region) of FMDV was introduced upstream of P1-2A to enhance the level of expression of cloned gene. Functionality of the vaccine construct was confirmed in vitro and in vivo. The self-replicating gene vaccine construct was tested in cattle in comparison with naked DNA vaccine carrying P1-2A and 3CD (pUP3CD). Humoral immune response by ELISA and SNT and cellular response by lymphoproliferation assay using MTT were studied. The default approach of using self replicating gene vaccine in high dose and multiple injection in cattle as followed in our studies might result in immunosuppression as this was observed in our subsequent experiments in guinea pigs. Hence based on dose response studies, vaccine strategy needs to be decided. However, the approach of using Sindbis polymerase gene and UTR in FMDV vaccine is the first report and shows future scope of developing such vaccines.
机译:DNA疫苗被认为是减毒活疫苗的替代品,可用于发现口蹄疫(FMD)等活疫苗生产和应用不成功的疾病。但是,DNA的稳定性和表达的抗原数量是裸DNA疫苗的主要限制。为了解决这些问题,针对口蹄疫病毒(O型)口蹄疫病毒(FMDV)制作了可自我复制的基因疫苗,并进行了研究。疫苗构建载体pSinCMVVac分别在Sindbis复制酶基因的5'和3'端带有CMV启动子和Poly(A)信号序列。在亚基因组启动子下,将FMDV血清型“ O”的结构蛋白前体(P1-2A)基因插入pSinCMVVac。将FMDV的5'UTR(非翻译区)引入P1-2A的上游,以增强克隆基因的表达水平。在体外和体内证实了疫苗构建体的功能。与携带P1-2A和3CD(pUP3CD)的裸DNA疫苗相比,在牛中测试了自我复制基因疫苗构建体。研究了采用ELISA和SNT进行的体液免疫反应以及采用MTT进行的淋巴增殖试验的细胞反应。按照我们的研究,在牛中使用高剂量自我复制基因疫苗并多次注射的默认方法可能会导致免疫抑制,因为我们在豚鼠的后续实验中观察到了这一点。因此,基于剂量反应研究,需要确定疫苗策略。然而,在FMDV疫苗中使用Sindbis聚合酶基因和UTR的方法是首次报道,并显示了开发此类疫苗的未来范围。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号